Facebook poaches City lobbying chief from Standard Chartered as it prepares cryptocurrency launch

Facebook poaches City lobbying chief from Standard Chartered as the tech giant prepares to launch its own cryptocurrencyBank's head of corporate...

Gold breaks above $1,350 level

Set for its fourth weekly gain, gold overnight jumped as much as 1.2% to $1,359.50, surpassing the key $1,350 level for the first time since April 2018. "When the markets start waxing bearish economic...

Hobson: DS Smith is Leader of the Packaging

Packaging – don’t you just hate it? We tear...

China data knocks FTSE as Woodford stock Kier slumps

Weakest Chinese industrial output growth in 17 years sends FTSE 100 lower and gold higher, while Neil Woodford-back Kier suffers fresh slump. READ SOURCE

Buy Zensar Technologies, target Rs 340: Elara Capital

Elara Capital has given a buy recommendation on Zensar Technologies with a target price of Rs 340. Shares of Zensar Technologies traded at Rs 256.9 around 2:25 pm on 14 June, 2019. The brokerage...

US-led ramp up in oil output undermining Opec cuts — IEA

Supply curbs by Opec are being undermined by “relentless” production growth outside of the cartel led by the US, a trend that will continue in 2020. The International Energy Agency said in its...

Best electric cars by real-world range that you can buy NOW

Got range anxiety? Here's how far you can expect to be able to travel in the latest electric models on sale in showrooms right nowFollowing Theresa...

FTSE LIVE: Shell Energy slapped with fine; Oil price choppy after Oman attack

FTSE LIVE: Shell Energy slapped with fine for overcharging; Oil price choppy after Oman attack; Blue-chip index and sterling both on...

Gold surges to near 14-month peak, set for fourth weekly gain

Gold prices rose on Friday, moving closer to their 14-month high hit last week, as trade and political turmoil, along with US interest rate cut expectations propped up the precious metal. FUNDAMENTALS Spot gold was...

Seres Therapeutics prices stock offering

Seres Therapeutics (MCRB) has priced public offering of 26.67M common shares at $2.25/share, for gross proceeds of $60M. Underwriters over-allotment is an additional 2.66M common shares. Closing date is...
CustomWritings.com is a professional coursework writing service for UK students.

Most Popular